GRAND RAPIDS, Mich., Aug. 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the

<p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass">GRAND RAPIDS, Mich.</span>, <span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass">Aug. 10, 2026</span> /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/SI">SI</a>), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the promotion of Jon Osborne to Chief Commercial Officer, effective August 6, 2026. Mr. Osborne, who most recently served as Vice President of Commercial Development, will now have responsibility for all elements of Shoulder Innovations&#39; commercial organization and will work closely with its Customer Experience and Medical Education team to execute the company&#39;s commercial strategy.</p>
    <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
                <p xmlns="http://www.w3.org/1999/xhtml">
                    <img xmlns="http://www.w3.org/1999/xhtml" src="https://mmx.prnewswire.com/media/MS1155725/Shoulder-Innovations-Logo.jpg?id=OA2844464" title="Shoulder Innovations company logo" alt="Shoulder Innovations company logo"></img>
                </p>
    </div>
<p xmlns="http://www.w3.org/1999/xhtml">&#34;Jon has consistently demonstrated exceptional leadership since joining Shoulder Innovations, and this promotion reflects the impact he&#39;s had on our rapid commercial success as a key architect of our go-to-market strategy,&#34; said Rob Ball, CEO of Shoulder Innovations. &#34;His depth of experience across the orthopedic industry, paired with his keen understanding of our business, strong relationships with our surgeon customers, and proven ability to execute, positions him well to lead our commercial organization as we continue to scale adoption of our broad and increasingly differentiated product portfolio.&#34;</p><p xmlns="http://www.w3.org/1999/xhtml">&#34;We&#39;re at an exciting point in our early journey of transforming the shoulder surgical care market for our customers and their patients, and I&#39;m looking forward to building on the strong commercial foundation that the entire Shoulder Innovations team has worked hard to build,&#34; said Jon Osborne. &#34;With this expanded role, my focus will be on further scaling the organization, deepening our surgeon and partner relationships, and ensuring our commercial execution keeps pace with the strength of our innovation engine.&#34;</p><p xmlns="http://www.w3.org/1999/xhtml">Prior to joining Shoulder Innovations as Vice President of Commercial Development in September 2023, Mr. Osborne held several positions of increasing responsibility from 2014 to 2023 at Smith &amp; Nephew Inc., most recently as Vice President of Commercial Marketing for the Sports Medicine business in the Americas. In this role, he was responsible for driving growth across a portfolio spanning joint repair, arthroscopic enabling technologies, biologics, and capital equipment, with additional oversight for outpatient and ambulatory surgery center initiatives. Earlier in his career at Smith &amp; Nephew Inc., he also served as an Area Vice President of Sales and as Director of Global Marketing, where he launched products and built distribution across six continents.</p><p xmlns="http://www.w3.org/1999/xhtml">Prior to Smith &amp; Nephew, Mr. Osborne worked in sales management, global marketing, and general management from 1998 to 2014 in both domestic and international markets at ArthroCare Corporation, Tornier USA, and Team Surgical, Inc. Mr. Osborne received his Bachelor of Arts in Public Relations from Miami University in Oxford, Ohio, and his Master of Business Administration from the Leeds School of Business at the University of Colorado.</p><p xmlns="http://www.w3.org/1999/xhtml"><b xmlns="http://www.w3.org/1999/xhtml">About Shoulder Innovations<br xmlns="http://www.w3.org/1999/xhtml"></br></b>Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations&#39; ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations&#39; ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.</p><p xmlns="http://www.w3.org/1999/xhtml"><b xmlns="http://www.w3.org/1999/xhtml">Contact</b> <br xmlns="http://www.w3.org/1999/xhtml"></br>Brian Johnston or Sam Bentzinger <br xmlns="http://www.w3.org/1999/xhtml"></br>Gilmartin Group LLC<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" href="mailto:ir@shoulderinnovations.com" target="_blank" rel="nofollow">ir@shoulderinnovations.com</a></p>



<p xmlns="http://www.w3.org/1999/xhtml" id="PURL"><img xmlns="http://www.w3.org/1999/xhtml" title="Cision" width="12" height="12" alt="Cision" src="https://edge.prnewswire.com/c/img/favicon.png?sn=FL22234&amp;sd=2026-08-10"></img> View original content to download multimedia:<a xmlns="http://www.w3.org/1999/xhtml" id="PRNURL" rel="nofollow" href="https://www.prnewswire.com/news-releases/shoulder-innovations-promotes-jon-osborne-to-chief-commercial-officer-302846661.html" target="_blank">https://www.prnewswire.com/news-releases/shoulder-innovations-promotes-jon-osborne-to-chief-commercial-officer-302846661.html</a></p><p xmlns="http://www.w3.org/1999/xhtml">SOURCE Shoulder Innovations</p>

Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

Shoulder Innovations promotes Jon Osborne to Chief Commercial Officer

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>GRAND RAPIDS, Mich., Aug. 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>Shoulder Innovations promoted Jon Osborne to Chief Commercial Officer, effective August 6, 2026, signaling a sharpened focus on scaling its commercial organization. Osborne brings extensive ortho industry experience from Smith &amp; Nephew and a track record of go-to-market execution. The move could accelerate adoption of the company&#039;s differentiated shoulder implants and supporting ecosystem.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Shoulder Innovations promotes Jon Osborne to Chief Commercial Officer. Effective Aug 6, 2026.</li><li>Osborne to oversee all commercial functions and scale adoption; 15 years in ortho.</li><li>CEO: Osborne strengthens surgeon relationships and execution.</li><li>Promotes leadership with orthopedic industry background.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Shoulder Innovations (SI)</strong>: Promotes Jon Osborne to Chief Commercial Officer; leadership move aimed at accelerating commercial execution.</li><li><strong>Smith &amp; Nephew plc (SNN)</strong>: Former employer of Osborne; provides credibility and depth in ortho go-to-market strategy.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>Category: Corporate Developments. Leadership change at the CCO level signals a strategic emphasis on scaling go-to-market efforts to drive adoption of the company&#039;s differentiated shoulder implants.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Leadership change may accelerate adoption of SI&#039;s shoulder implant portfolio.</li><li>Effective date provided: August 6, 2026, giving a clear transition timeline.</li><li>Market reaction may be modest given small-cap status but credibility improves.</li><li>Osborne&#039;s Smith &amp; Nephew background adds credibility with surgeon customers.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Effective date: August 6, 2026.</li><li>Role: Chief Commercial Officer.</li><li>Promoted from VP, Commercial Development (joined 2023).</li><li>Past employer: Smith &amp; Nephew Inc. (2014-2023).</li><li>Company ticker: NYSE SI.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Bullish in the near term on improved go-to-market execution, likely 3–6 months of sales traction.</p>
  </section>
</section>


<p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass">GRAND RAPIDS, Mich.</span>, <span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass">Aug. 10, 2026</span> /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/SI">SI</a>), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the promotion of Jon Osborne to Chief Commercial Officer, effective August 6, 2026. Mr. Osborne, who most recently served as Vice President of Commercial Development, will now have responsibility for all elements of Shoulder Innovations&#39; commercial organization and will work closely with its Customer Experience and Medical Education team to execute the company&#39;s commercial strategy.</p>
    <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
                <p xmlns="http://www.w3.org/1999/xhtml">
                    <img xmlns="http://www.w3.org/1999/xhtml" src="https://mmx.prnewswire.com/media/MS1155725/Shoulder-Innovations-Logo.jpg?id=OA2844464" title="Shoulder Innovations company logo" alt="Shoulder Innovations company logo"></img>
                </p>
    </div>
<p xmlns="http://www.w3.org/1999/xhtml">&#34;Jon has consistently demonstrated exceptional leadership since joining Shoulder Innovations, and this promotion reflects the impact he&#39;s had on our rapid commercial success as a key architect of our go-to-market strategy,&#34; said Rob Ball, CEO of Shoulder Innovations. &#34;His depth of experience across the orthopedic industry, paired with his keen understanding of our business, strong relationships with our surgeon customers, and proven ability to execute, positions him well to lead our commercial organization as we continue to scale adoption of our broad and increasingly differentiated product portfolio.&#34;</p><p xmlns="http://www.w3.org/1999/xhtml">&#34;We&#39;re at an exciting point in our early journey of transforming the shoulder surgical care market for our customers and their patients, and I&#39;m looking forward to building on the strong commercial foundation that the entire Shoulder Innovations team has worked hard to build,&#34; said Jon Osborne. &#34;With this expanded role, my focus will be on further scaling the organization, deepening our surgeon and partner relationships, and ensuring our commercial execution keeps pace with the strength of our innovation engine.&#34;</p><p xmlns="http://www.w3.org/1999/xhtml">Prior to joining Shoulder Innovations as Vice President of Commercial Development in September 2023, Mr. Osborne held several positions of increasing responsibility from 2014 to 2023 at Smith &amp; Nephew Inc., most recently as Vice President of Commercial Marketing for the Sports Medicine business in the Americas. In this role, he was responsible for driving growth across a portfolio spanning joint repair, arthroscopic enabling technologies, biologics, and capital equipment, with additional oversight for outpatient and ambulatory surgery center initiatives. Earlier in his career at Smith &amp; Nephew Inc., he also served as an Area Vice President of Sales and as Director of Global Marketing, where he launched products and built distribution across six continents.</p><p xmlns="http://www.w3.org/1999/xhtml">Prior to Smith &amp; Nephew, Mr. Osborne worked in sales management, global marketing, and general management from 1998 to 2014 in both domestic and international markets at ArthroCare Corporation, Tornier USA, and Team Surgical, Inc. Mr. Osborne received his Bachelor of Arts in Public Relations from Miami University in Oxford, Ohio, and his Master of Business Administration from the Leeds School of Business at the University of Colorado.</p><p xmlns="http://www.w3.org/1999/xhtml"><b xmlns="http://www.w3.org/1999/xhtml">About Shoulder Innovations<br xmlns="http://www.w3.org/1999/xhtml"></br></b>Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations&#39; ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations&#39; ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.</p><p xmlns="http://www.w3.org/1999/xhtml"><b xmlns="http://www.w3.org/1999/xhtml">Contact</b> <br xmlns="http://www.w3.org/1999/xhtml"></br>Brian Johnston or Sam Bentzinger <br xmlns="http://www.w3.org/1999/xhtml"></br>Gilmartin Group LLC<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" href="mailto:ir@shoulderinnovations.com" target="_blank" rel="nofollow">ir@shoulderinnovations.com</a></p>



<p xmlns="http://www.w3.org/1999/xhtml" id="PURL"><img xmlns="http://www.w3.org/1999/xhtml" title="Cision" width="12" height="12" alt="Cision" src="https://edge.prnewswire.com/c/img/favicon.png?sn=FL22234&amp;sd=2026-08-10"></img> View original content to download multimedia:<a xmlns="http://www.w3.org/1999/xhtml" id="PRNURL" rel="nofollow" href="https://www.prnewswire.com/news-releases/shoulder-innovations-promotes-jon-osborne-to-chief-commercial-officer-302846661.html" target="_blank">https://www.prnewswire.com/news-releases/shoulder-innovations-promotes-jon-osborne-to-chief-commercial-officer-302846661.html</a></p><p xmlns="http://www.w3.org/1999/xhtml">SOURCE Shoulder Innovations</p>

Shoulder Innovations promoted Jon Osborne to Chief Commercial Officer, effective August 6, 2026, signaling a sharpened focus on scaling its commercial organization. Osborne brings extensive ortho industry experience from Smith & Nephew and a track record of go-to-market execution. The move could accelerate adoption of the company's differentiated shoulder implants and supporting ecosystem.

News insight

Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

AI summary

Sentiment rationale

Key facts

Corporate Developments